Federico Cresta

575 total citations
27 papers, 343 citations indexed

About

Federico Cresta is a scholar working on Pulmonary and Respiratory Medicine, Neurology and Speech and Hearing. According to data from OpenAlex, Federico Cresta has authored 27 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 3 papers in Neurology and 3 papers in Speech and Hearing. Recurrent topics in Federico Cresta's work include Cystic Fibrosis Research Advances (22 papers), Neonatal Respiratory Health Research (10 papers) and Tracheal and airway disorders (6 papers). Federico Cresta is often cited by papers focused on Cystic Fibrosis Research Advances (22 papers), Neonatal Respiratory Health Research (10 papers) and Tracheal and airway disorders (6 papers). Federico Cresta collaborates with scholars based in Italy, France and Switzerland. Federico Cresta's co-authors include Carlo Castellani, Rosaria Casciaro, Luis J. V. Galietta, L. Minicucci, Aldo Naselli, Nicoletta Pedemonte, V. Lucidi, Vito Terlizzi, Valeria Capurro and Elvira Sondo and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Cellular and Molecular Life Sciences.

In The Last Decade

Federico Cresta

26 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Federico Cresta Italy 13 268 50 45 26 26 27 343
Ifat Sarouk Israel 11 215 0.8× 122 2.4× 42 0.9× 22 0.8× 31 1.2× 31 384
David Waltz United States 7 603 2.3× 105 2.1× 63 1.4× 6 0.2× 47 1.8× 11 648
K.W. Southern United Kingdom 7 209 0.8× 119 2.4× 19 0.4× 25 1.0× 16 0.6× 20 348
Damien Adam Canada 11 228 0.9× 89 1.8× 55 1.2× 22 0.8× 20 0.8× 29 382
Dov Virgilis Israel 6 108 0.4× 160 3.2× 25 0.6× 4 0.2× 15 0.6× 9 301
M Jorissen Belgium 10 170 0.6× 58 1.2× 85 1.9× 12 0.5× 15 0.6× 14 502
Brigitte Wulf Germany 6 311 1.2× 45 0.9× 10 0.2× 5 0.2× 16 0.6× 9 353
Lacey Kruse United States 10 39 0.1× 55 1.1× 66 1.5× 20 0.8× 28 1.1× 23 337
Whitney Wolf United States 5 172 0.6× 61 1.2× 7 0.2× 11 0.4× 60 2.3× 12 243
G Baktai Hungary 3 320 1.2× 27 0.5× 46 1.0× 3 0.1× 37 1.4× 3 359

Countries citing papers authored by Federico Cresta

Since Specialization
Citations

This map shows the geographic impact of Federico Cresta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Cresta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Cresta more than expected).

Fields of papers citing papers by Federico Cresta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federico Cresta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Cresta. The network helps show where Federico Cresta may publish in the future.

Co-authorship network of co-authors of Federico Cresta

This figure shows the co-authorship network connecting the top 25 collaborators of Federico Cresta. A scholar is included among the top collaborators of Federico Cresta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federico Cresta. Federico Cresta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Bassi, Marta, Federico Cresta, Giuseppe d’Annunzio, et al.. (2024). Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: a pilot study. Frontiers in Endocrinology. 15. 1347141–1347141. 1 indexed citations
4.
Pedrazzi, Marco, Roberta De Tullio, Marcello Manfredi, et al.. (2023). Modulation of Plasmatic Matrix Metalloprotease 9: A Promising New Tool for Understanding the Variable Clinical Responses of Patients with Cystic Fibrosis to Cystic Fibrosis Transmembrane Conductance Regulator Modulators. International Journal of Molecular Sciences. 24(17). 13384–13384. 1 indexed citations
5.
Amerio, Andrea, Carlo Castellani, Irene Schiavetti, et al.. (2023). The Expression of Affective Temperaments in Cystic Fibrosis Patients: Psychopathological Associations and Possible Neurobiological Mechanisms. Brain Sciences. 13(4). 619–619.
6.
Barco, Sebastiano, Nicoletta Pedemonte, Federico Cresta, et al.. (2023). Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method. Biomedicines. 11(2). 628–628. 15 indexed citations
7.
8.
Tomati, Valeria, Stefano Costa, Valeria Capurro, et al.. (2022). Rescue by elexacaftor-tezacaftor-ivacaftor of the G1244E cystic fibrosis mutation's stability and gating defects are dependent on cell background. Journal of Cystic Fibrosis. 22(3). 525–537. 19 indexed citations
9.
Borgo, Christian, Claudio D’Amore, Valeria Capurro, et al.. (2022). Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants. Cellular and Molecular Life Sciences. 79(4). 192–192. 13 indexed citations
10.
Pedrazzi, Marco, Elettra Barberis, Roberta De Tullio, et al.. (2021). Identification of Potential Leukocyte Biomarkers Related to Drug Recovery of CFTR: Clinical Applications in Cystic Fibrosis. International Journal of Molecular Sciences. 22(8). 3928–3928. 12 indexed citations
11.
Casciaro, Rosaria, et al.. (2021). SARS-CoV-2 and Burkholderia cenocepacia infection in a patient with Cystic Fibrosis: An unfavourable conjunction?. Journal of Cystic Fibrosis. 20(3). e29–e31. 3 indexed citations
12.
Salvatore, Donatello, Vito Terlizzi, Michela Francalanci, et al.. (2020). Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function. Respiratory Medicine. 171. 106073–106073. 24 indexed citations
13.
Furnari, Manuele, A. De Alessandri, Federico Cresta, et al.. (2018). The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin. Journal of Gastroenterology. 54(3). 261–270. 33 indexed citations
14.
Averna, Monica, Federico Cresta, Marco Pedrazzi, et al.. (2016). Abnormal activation of calpain and protein kinase Cα promotes a constitutive release of matrix metalloproteinase 9 in peripheral blood mononuclear cells from cystic fibrosis patients. Archives of Biochemistry and Biophysics. 604. 103–112. 13 indexed citations
15.
Naselli, Aldo, et al.. (2015). A long-term follow-up of residual mass neuroblastoma in a patient with cystic fibrosis. BMJ Case Reports. 2015. bcr2014205284–bcr2014205284. 2 indexed citations
16.
Terlizzi, Vito, Vincenzo Carnovale, Giuseppe Castaldo, et al.. (2015). Clinical expression of patients with the D1152H CFTR mutation. Journal of Cystic Fibrosis. 14(4). 447–452. 39 indexed citations
17.
Cresta, Federico, et al.. (2013). Inhaled hypertonic saline+hyaluronic acid in cystic fibrosis with asthma-like symptoms: a new therapeutic chance. BMJ Case Reports. 2013. bcr2013009042–bcr2013009042. 6 indexed citations
18.
Averna, Monica, Marco Pedrazzi, L. Minicucci, et al.. (2013). Calpain Inhibition Promotes the Rescue of F508del-CFTR in PBMC from Cystic Fibrosis Patients. PLoS ONE. 8(6). e66089–e66089. 5 indexed citations
19.
Averna, Monica, Roberto Stifanese, Roberta De Tullio, et al.. (2011). Evidence for alteration of calpain/calpastatin system in PBMC of cystic fibrosis patients. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(12). 1649–1657. 10 indexed citations
20.
Rosa, U., et al.. (1965). PROTEINS RADIOIODINATION BY AN ELECTROLYTIC TECHNIQUE,. Defense Technical Information Center (DTIC). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ifat Sarouk Breakdown of academic impact, for papers by David Waltz Breakdown of academic impact, for papers by K.W. Southern Breakdown of academic impact, for papers by Damien Adam Breakdown of academic impact, for papers by Dov Virgilis Breakdown of academic impact, for papers by M Jorissen Breakdown of academic impact, for papers by Brigitte Wulf Breakdown of academic impact, for papers by Lacey Kruse Breakdown of academic impact, for papers by Whitney Wolf Breakdown of academic impact, for papers by G Baktai
Rankless by CCL
2026